Johnson & Johnson cited the strength of key brands in its U.S. over-the-counter business as one of the driving factors that led to what chairman and CEO Alex Gorsky called “outstanding” results for the fourth quarter.
Johnson & Johnson chairman and CEO Alex Gorsky told shareholders at the company's annual shareholder meeting that its consumer healthcare business would reclaim its prominence in the U.S. marketplace. But OTC growth will be greatest outside of the U.S.
Johnson & Johnson has elected Alex Gorsky as its new chairman, board of directors, effective December 28. Gorsky, who was appointed CEO in April of this year, replaces current chairman Bill Weldon, who was with the company for 41 years.